Alkem Laboratories Ltd share price logo

Alkem Labs Share Price

NSE: ALKEM

BSE: 539523

Mid Cap

Healthcare Sector

₹5163.00

-94.50

(-1.80%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Alkem Labs Stock Performance

as on March 23, 2026 at 5:38 pm IST

  • Day's Low

    Day's High

    ₹5,111.50
    ₹5,272.50
    downward going graph

    1.00%

    Downside

    2.12%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹4,611.85
    ₹5,933.50
    downward going graph

    10.67%

    Downside

    14.92%

    Upside

    downward going graph

Alkem Labs share price movements today

Previous Close
₹5,257.50
Open
₹5,157.00
Volume
49.15K
Upper Circuit
₹5,783.00
Lower Circuit
₹4,732.00
Day's Low - High
₹5,111.50 - ₹5,272.50
52 Week Low - High
₹4,611.85 - ₹5,933.50

Alkem Labs Historical Returns

1 Month Return
-4.24 %
3 Month Return
-6.07 %
1 Year Return
+ 4.06 %
3 Year Return
+ 66.92 %
5 Year Return
+ 102.41 %

Alkem Labs Fundamentals

as on March 23, 2026 at 12:08 pm IST

Market Cap

₹62,861.30 Cr

Return on Equity (ROE)

19.94

PE Ratio (TTM)

26.51

Return on capital employed (ROCE)

20.29

Industry PE ratio

40.5

Beta (LTM)

0.77

P/B Ratio

4.73

Dividend Yield

0.92

PEG Ratio

1.46

Quarterly Earnings Growth YOY

1.99

EPS (TTM)

185.36

Sector

Pharmaceuticals

Book Value

1002.5

Technical Analysis

Bearish

View Technical Analysis

Alkem Labs Stock Valuation

as on March 23, 2026 at 12:08 pm IST

Alkem Labs in the last 5 years

  • Overview

  • Trends

Lowest (20.07x)

March 24, 2021

Today (26.51x)

March 20, 2026

Industry (40.50x)

March 20, 2026

Highest (44.21x)

August 9, 2023

LowHigh

Today’s Price to Earnings Ratio: 26.51x

Alkem Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alkem Labs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Alkem Laboratories Ltd image
Alkem Laboratories Ltd
HOLD62,861.3020.48%0.592,21612,964
Dr Lal Pathlabs Ltd image
Dr Lal Pathlabs Ltd
BUY21,919.550.46%0.544922,461
Laurus Labs Ltd image
Laurus Labs Ltd
HOLD53,294.6434.66%0.713545,553
Vijaya Diagnostic Centre Ltd image
Vijaya Diagnostic Centre Ltd
BUY9,308.049.18%0.65143704
Thyrocare Technologies Ltd image
Thyrocare Technologies Ltd
BUY5,592.274.34%0.5390687
See all

Market expectation of Alkem Labs Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

42.11%

Buy

42.11%

Hold

15.79%

Sell

Alkem Labs Stock’s Investor Sentiment and Interest

Search interest for Alkem Laboratories Ltd Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

Alkem Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
2,902.6
2,967.72
3,440.17
3,323.87
2,935.82
3,031.82
3,414.67
3,374.28
3,143.75
3,371.14
4,000.99
3,736.82
Other Income
68.67
65.84
63.19
93.64
88.17
120.31
134.48
92.99
145.96
149.42
103.69
143.1
Total Income
2,971.27
3,033.56
3,503.36
3,417.51
3,023.99
3,152.13
3,549.15
3,467.27
3,289.71
3,520.56
4,104.68
3,879.92
Expenses
2,652.33
2,578.53
2,751.1
2,667.59
2,546.36
2,423.18
2,661.84
2,614.89
2,752.46
2,632.09
3,080.22
2,961.61
Operating Profit
250.27
389.19
689.07
656.28
389.46
608.64
752.83
759.39
391.29
739.05
920.77
775.21
Operating Profit Margin %
8.62%
13.11%
20.03%
19.74%
13.27%
20.08%
22.05%
22.51%
12.45%
21.92%
23.01%
20.75%
Profit Before Interest, Tax and Depreciation
318.94
455.03
752.26
749.92
477.63
728.95
887.31
852.38
537.25
888.47
1,024.46
918.31
Interest
28.96
29.77
30.32
25.46
26.86
29.11
28.14
36.03
28.42
29.78
35.02
42.1
Depreciation
78.32
72.41
73.9
69.56
83.43
80.48
78.91
85.28
112.49
87.68
93.61
95.01
Profit Before Tax
211.66
352.85
648.04
654.9
367.34
619.36
780.26
731.07
396.34
771.01
895.83
781.2
Tax Paid
143.98
65.04
33.15
50.62
62.86
69.12
78.3
90.28
73.33
102.69
116.23
127.67
Profit After Tax
67.68
287.81
614.89
604.28
304.48
550.24
701.96
640.79
323.01
668.32
779.6
653.53
Total Net profit including share of profit / Loss from associate company
67.68
287.81
614.89
604.28
304.48
550.24
701.96
640.79
322.39
667.91
779.11
653.03
EPS
5.94
23.98
51.9
49.76
24.55
45.6
57.6
52.34
25.57
55.56
63.99
53.19
Actual EPS
5.94
23.98
51.9
49.76
24.55
45.6
57.6
52.34
25.57
55.56
63.99
53.19
Adjusted EPS
5.94
23.98
51.9
49.76
24.55
45.6
57.6
52.34
25.57
55.56
63.99
53.19
Diluted EPS
5.94
23.98
51.9
49.76
24.55
45.6
57.6
52.34
25.57
55.56
63.99
53.19

Alkem Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
5,852.5
6,401.17
7,357.19
8,344.36
8,865.01
10,634.19
11,599.26
12,667.58
12,964.52
Other Income
112.01
115.42
87.7
104.22
233.21
162.65
216.08
310.84
493.74
Total Income
5,964.51
6,516.59
7,444.89
8,448.58
9,098.22
10,796.84
11,815.34
12,978.42
13,458.26
Expenses
4,853.55
5,392.25
6,242.42
6,870.97
6,922.62
8,596.23
10,092.79
10,543.58
10,452.37
Operating Profit
998.95
1,008.92
1,114.77
1,473.39
1,942.39
2,037.96
1,506.47
2,124
2,512.15
Operating Profit Margin %
17.07%
15.76%
15.15%
17.66%
21.91%
19.16%
12.99%
16.77%
19.38%
Profit Before Interest, Tax and Depreciation
1,110.96
1,124.34
1,202.47
1,577.61
2,175.6
2,200.61
1,722.55
2,434.84
3,005.89
Interest
45.16
55.33
54.63
65.06
58.92
52.37
107.36
112.41
121.7
Depreciation
101.17
143.03
193.18
252.76
274.58
303.96
310.42
299.3
357.16
Profit Before Tax
964.63
925.98
954.66
1,259.79
1,842.1
1,844.28
1,304.77
2,023.13
2,527.03
Tax Paid
59.96
287.56
181.02
110.48
224.33
163.96
297.96
211.67
311.03
Profit After Tax
904.67
638.42
773.64
1,149.31
1,617.77
1,680.32
1,006.81
1,811.46
2,216
Total Net profit including share of profit / Loss from associate company
904.67
638.42
773.64
1,149.31
1,617.77
1,680.32
1,006.81
1,811.46
2,215.38
EPS
74.61
52.77
63.61
94.26
132.57
137.63
82.31
150.19
181.11
Actual EPS
74.61
52.77
63.61
94.26
132.57
137.63
82.31
150.19
181.11
Adjusted EPS
74.61
52.77
63.61
94.26
132.57
137.63
82.31
150.19
181.11
Diluted EPS
74.61
52.77
63.61
94.26
132.57
137.63
82.31
150.19
181.11

Alkem Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
725.84
471.13
266.04
779.65
585.08
1,264.9
1,111.02
1,682.5
1,948.07
1,912.84
Cash Flow from Investing Activities
204.74
-294.06
-350.52
-318.37
-737.34
-994.87
-1,432.63
119.94
-1,010.55
-1,288.25
Cash Flow from Financing Activities
-927.27
-137.88
84.56
-378.94
79.15
-271.75
379.57
-1,760.82
-1,145.01
-810.99
Net Cash Flow
3.31
39.58
0.08
82.34
-73.11
-1.72
57.96
41.62
-207.49
-186.4

Alkem Labs Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
57.16%
56.74%
56.74%
56.74%
56.38%
55.66%
55.66%
55.13%
53.04%
51.2%
51.2%
DII
15.43%
17.64%
14.94%
15.63%
18.57%
19.21%
18.01%
19.42%
21.8%
21.93%
21.54%
FII
0%
0%
0%
9.11%
8.69%
9.02%
10.15%
9.41%
9.11%
9.48%
9.97%
Public
20.86%
19.59%
18.86%
18.52%
16.36%
16.1%
16.18%
16.05%
16.05%
17.4%
17.3%
Total Outstanding Shares
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
Total Shareholders
66,790
69,442
65,184
65,830
69,627
74,744
84,038
84,326
79,740
67,196
64,536

Mutual Funds that own Alkem Labs Stock

Check out the Mutual Funds with significant holdings in Alkem Labs.

Alkem Labs Corporate Actions

View detailed summary of the earnings and dividend history of Alkem Labs.

  • Alkem Laboratories Ltd Earnings Results

    Alkem Laboratories Ltd’s net profit jumped 1.63% since last year same period to ₹636.02Cr in the Q3 2025-2026. On a quarterly growth basis, Alkem Laboratories Ltd has generated -16.87% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Alkem Laboratories Ltd Dividends February,2026

    In the quarter ending December 2025, Alkem Laboratories Ltd has declared dividend of ₹43.00 per share on 13 Feb 2026 - translating a dividend yield of 0.97%.

    Read More about Dividends

Alkem Labs News & Key Events

  • img

    Today's Timeline - 23 March

    07:22 AM

    -

    Alkem Laboratories receives DCGI approval for Semaglutide Injection, launching it at Rs 1,800 for a month's dosage.

Indices Featuring Alkem Labs Stock

Check stock indices that include Alkem Labs.

BSE 200

₹10,245.28

-2.89 (▲304.60%)

Nifty Midcap 100

₹52,833.15

-3.69 (▲2022.35%)

Nifty Midcap 150

₹19,474.25

-3.72 (▲752.65%)

NIFTY PHARMA

₹22,204.05

-1.49 (▲336.65%)

S&P BSE 150 MidCap

₹14,296.55

-3.69 (▲547.88%)

Nifty 200

₹12,609.20

-2.90 (▲376.20%)

S&P BSE 400 MidSmallCap

₹10,470.39

-3.73 (▲405.79%)

S&P BSE 250 LargeMidCap

₹9,711.22

-2.93 (▲292.88%)

Nifty LargeMidcap 250

₹14,667.80

-3.22 (▲488.80%)

BSE Healthcare

₹41,430.59

-2.07 (▲875.81%)

Nifty Healthcare

₹14,126.65

-1.79 (▲256.80%)

Nifty MidSmallcap 400

₹17,525.95

-3.75 (▲682.60%)

Nifty 500

₹20,683.55

-3.02 (▲644.35%)

BSE 500

₹32,417.45

-3.01 (▲1006.16%)

Insights on Alkem Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 9.48% to 9.97% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 30.5% return, outperforming this stock by 26.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.20% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 178.9% return, outperforming this stock by 112.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 17.40% to 17.30% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 4.10K Cr → 3.87K Cr (in ₹), with an average decrease of 5.5% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 765.06 Cr → 636.02 Cr (in ₹), with an average decrease of 16.9% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 16.94% to 16.06% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, ALKEM stock has moved down by -5.2%

Alkem Labs Stock Futures & Options Contracts

View the latest movement in Alkem Labs Futures & Options, including strike prices, expiry dates, and percentage changes.

Alkem Labs Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ALKEM 30 Mar ₹5300 Call
March 30, 2026
₹5300
₹35.7
-25.7
-41.86%
ALKEM 30 Mar ₹5500 Call
March 30, 2026
₹5500
₹8.4
-3.5
-29.41%
ALKEM 30 Mar ₹5200 Call
March 30, 2026
₹5200
₹72.5
-33.45
-31.57%
ALKEM 30 Mar ₹5400 Call
March 30, 2026
₹5400
₹15.35
-10.85
-41.41%

Alkem Labs Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ALKEM 30 Mar Fut
March 30, 2026
-
₹5172.5
-79.84
-1.52%
ALKEM 28 Apr Fut
April 28, 2026
-
₹5199
-85.61
-1.62%
ALKEM 26 May Fut
May 26, 2026
-
₹5307.5
-177.15
-3.23%

About Alkem Laboratories Ltd

Alkem Laboratories Ltd is a leading pharmaceutical company founded in 1973 by Mr. Samir C. Desai.

With its headquarters in Mumbai, India, Alkem Laboratories is engaged in the manufacture of a wide range of pharmaceutical products across multiple therapeutic categories, including cardiovascular, central nervous system, gastro-intestinal, anti-infective, diabetology, and nutrition. The company has a strong presence in the Indian market and exports its products to over 50 countries.

Revenue: ₹3,736.82Cr as on December 2025 (Q3 FY26)
Net Profit: ₹653.53Cr as on December 2025 (Q3 FY26)
Listing date: 23 Dec, 2015
Chairperson Name: Basudeo N Singh
OrganisationAlkem Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOBasudeo N Singh
E-voting on sharesClick here to vote

FAQs

What is Alkem Labs share price today?

Alkem Labs share price today stands at ₹5163 as on . Alkem Labs share today touched a day high of ₹5272.5 and a low of ₹5111.5.

What is the 52 week high and 52 week low range for Alkem Labs share?

Alkem Labs touched a 52 week high of ₹5933.5 and a 52 week low of ₹4611.85. Alkem Labs share price today i.e. is trending at ₹5163, which is -12.99% down from its 52 week high and 11.95% up from its 52 week low.

What is Alkem Labs's market capitalisation today?

Alkem Labs market capitalisation is ₹62,861.30 Cr as on .

How to buy Alkem Labs shares?

To buy Alkem Labs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ALKEM or Alkem Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Alkem Labs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Alkem Labs trading volume today?

Alkem Labs trading volume is 49.15K as on . This means that 49.15K shares of Alkem Labs were bought and sold on the stock market during today's trading session.